Thursday, 17 August 2017

Biologics News

  • 3SBio to develop antibody for acute leukemia

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2014

    Singapore: Chinese biotechnology firm, 3SBio, has signed an exclusive license with Korean firm, DiNonA  for the development, manufacturing and marketing of Leukotuximab. It is an anti JL-1...Read more

  • Detect drug resistant TB in a jiffy

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 25 Sep, 2014

    Singapore: Soon, a simple breath test will detect whether a person is infected with a drug resistant tuberculosis strain or the normal strain. Scientists at the University of New Mexico, Al...Read more

  • Breast cancer boasts of highest drug pipeline'

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 08 Sep, 2014

    Singapore: Breast cancer therapeutics pipeline has higher innovation in first-in-class molecules, with many new technologies holding the potential to transform the clinical and commercial t...Read more

  • AbbVie aquires API manufacturing firm in Singapore

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 25 Nov, 2014

    Singapore: AbbVie, a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott, has acquired a small molecule active pharmaceutical ingredient (API) m...Read more

  • Test to detect bird flu mutants

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 03 Nov, 2014

    Singapore: Australian scientists have developed a new test that can detect bird flu mutation by distinguishing between birds that have been vaccinated against the H5N1 strain of influenza v...Read more

  • Ebola vaccine trial update

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 03 Oct, 2014

    Singapore: WHO, in consultation with over 70 experts, is assessing the status of two Ebola vaccine candidates for their safety and efficacy potential.The two candidate vaccines have clinica...Read more

  • Roche to acquire Santaris Pharma for $450 mn

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 05 Aug, 2014

    Singapore: Global biopharmaceutical firm, Roche, is all set to acquire Santaris Pharma, a Denmark based biopharmaceutical company, that has developed Locked Nucleic Acid (LNA) platform to s...Read more

  • Beike awaits CFDA nod for stem cell application

    Biologics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 14 Jul, 2014

    Singapore: China-based Beike Biotechnology has recieved Chinese Food and Drug Administration (CFDA) nod for filing the approval application for human umbilical cord (UC) derived mesenchymal...Read more

  • Danish firm, Aussie instiute to co-develop pathological drugs

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 08 Nov, 2013

    Singapore: Danish firm, Mirrx Therapeutics and Australia's Centenary Institute of Cancer Medicine and Cell Biology has formed a collaboration and commercialisation agreement, which formalis...Read more

  • WHO sets timeline for ebola vaccine

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 03 Oct, 2014

    Singapore: From September 29-30, 2014, WHO organized an expert consultation to assess the groundwork of ebola vaccine development and concluded with an expected milestone to develop and lau...Read more

  • BI to enhance investment in Austria

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 28 Dec, 2015

    Singapore: Boehringer Ingelheim plans to establish a new large-scale biopharmaceutical production facility for active ingredients manufactured using cell cultures in Vienna with a rough inv...Read more

  • China Cord Blood gets US accredition

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2015

    Singapore: Guangdong subsidiary of China Cord Blood Corporation, a provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services,...Read more

  • Asthma therapy market to touch $23.1 bn by 2023

    Biologics |  Analysis | By BioSpectrum Bureau | 0 Comment | 08 Sep, 2014

    Singapore: Asthma treatment market value will grow from approximately USD15.9 billion in 2013, across eight major countries including US, UK, France, Germany, Spain, Italy, Japan and Austra...Read more

  • Nanodiamonds can be an effective cancer drug carrier

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2015

    Singapore: A study led by the National University of Singapore (NUS) has found that attaching chemotherapy drug Epirubicin to nanodiamonds effectively eliminates chemoresistant cancer stem ...Read more

  • India firm launches biosimilar for autoimmune disease

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 10 Dec, 2014

    Singapore: India-based Zydus Cadila has launched the biosimilar of Adalimumab, indicated for the treatment of auto immune disorders such as rheumatoid arthritis, juvenile idiopathic arthrit...Read more

  • China Biologic to manufacture PCC at Shandong Taibang facility

    Biologics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 20 Oct, 2014

    Singapore: China Biologic Products, China-based biopharmaceutical company, has received China Food and Drug Administration (CFDA) approval for commercial manufacturing of human prothrombin ...Read more

  • NIH discovers new animal model for MERS testing

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2014

    Singapore: Researchers at the National Institute of Health (NIH) have found that immune responses instigated by MERS infection in humans and marmosets were very similar. They said that marm...Read more

  • Sanofi and Boehringer to manufacture biologics

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 19 Jan, 2015

    Singapore: Under the terms of the agreement, Sanofi will have access to Boehringer Ingelheim's capabilities in Biberach an der Riss, Germany, to transfer and manufacture therapeutic mAbs. ...Read more

Orchard Therapeutics appoin...

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls